New York State Common Retirement Fund Nuvectis Pharma, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$5.98 - $8.25 $33,996 - $46,901	-5,685 Reduced 98.89%	64 $0
Q1 2024 May 07, 2024	SELL	$6.69 - $11.0 $153 - $253	-23 Reduced 0.4%	5,749 $47,000
Q3 2023 Nov 07, 2023	BUY	$12.89 - $16.29 $928 - $1,172	72 Added 1.26%	5,772 $74,000
Q2 2023 Aug 07, 2023	BUY	$12.62 - $18.4 $71,934 - $104,879	5,700 New	5,700 $91,000

1.65M

Ticker NVCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,642,500
Market Cap $68.8M
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.